Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NPI 1699260083
NPI deactivated

1699260083

1699260083 was paid $1.38M by Medicaid between Sep 2019 and Mar 2024, across 41 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.

33Billing provider info1699260083
33aNPI1699260083
33bProvider type—
28Total paid$1.38M
24GClaims70,508
24DCodes billed41
24AFirst – last monthSep 2019 – Mar 2024
Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20193,327$44K
202010,220$205K
202114,333$245K
202217,449$353K
202322,331$436K
2024incomplete2,848$99K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 31% 15,620 11,741 $426K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 16% 6,673 2,835 $223K
99205 Prolong outpt/office vis 11% 2,513 1,930 $154K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 9.3% 3,285 2,413 $129K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 8.7% 6,111 4,795 $121K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 4.4% 1,233 931 $61K
J9271 Injection, pembrolizumab, 1 mg 3.6% 44 25 $50K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 3.3% 1,119 863 $46K
96417 2.9% 1,735 878 $41K
99195 1.8% 1,044 614 $25K
96401 1.1% 728 479 $15K
96416 1.0% 472 115 $14K
29 more codes
96411 1.0% 662 $14K
96367 <1% 3,928 $10K
96415 <1% 960 $9K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 3,014 $8K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,472 $7K
96375 Therapeutic injection; each additional sequential IV push <1% 3,110 $5K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,051 $5K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 4,126 $5K
96402 <1% 425 $4K
J1453 Injection, fosaprepitant, 1 mg <1% 111 $2K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 516 $2K
J9190 Injection, fluorouracil, 500 mg <1% 642 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,419 $872.45
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,071 $851.33
36591 <1% 459 $846.29
99223 Prolong inpt eval add15 m <1% 17 $824.33
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 46 $668.38
J3490 Unclassified drugs <1% 1,323 $663.33
J3489 Injection, zoledronic acid, 1 mg <1% 16 $199.45
J7030 Infusion, normal saline solution , 1000 cc <1% 109 $186.82
96377 <1% 72 $177.64
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 332 $160.86
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 227 $90.61
96368 <1% 260 $48.70
J2780 Injection, ranitidine hydrochloride, 25 mg <1% 27 $47.91
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 75 $7.22
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 366 $0.92
S0028 Injection, famotidine, 20 mg 0% 57 $0.00
96523 0% 38 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.